Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancers (NSCLC) account for 85–90% of all lung cancers. As drug resistance critically impairs chemotherapy effectiveness, there is great need to identify new therapeutic targets. The aims of this study were to investigate the prognostic and therapeutic potential of th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Suraweera, Amila, Duff, Alex, Adams, Mark N., Jekimovs, Christian, Duijf, Pascal H. G., Liu, Cheng, McTaggart, Matthew, Beard, Sam, O’Byrne, Kenneth J., Richard, Derek J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434762/
https://ncbi.nlm.nih.gov/pubmed/32439936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0899-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky